Literature DB >> 35344188

The rationale and potential for using Lactobacillus in the management of periodontitis.

Jiaqi Wang1, Yingman Liu1, Weiru Wang1, Jiaojiao Ma1, Manman Zhang2, Xiaoying Lu2, Jie Liu3, Yurong Kou4,5.   

Abstract

Periodontitis refers to a wide range of the inflammatory conditions of supporting dental structures. For some patients with periodontitis, antibacterial agents are needed as an adjuvant to mechanical debridement treatments and oral hygiene maintenance. However, the widespread use of broad-spectrum antibiotics for the prophylaxis and treatment of periodontal infections results in the emergence of resistant pathogens. Therefore, probiotics have become markedly interesting to researchers as a potentially safe alternative to periodontal treatment and maintenance. Probiotics have been used in medicine for decades and extensively applied to the treatment of inflammatory diseases through the modulation of microbial synergy and other mechanisms. A growing amount of evidence has shown that using Lactobacillus strains for oral cavity maintenance could improve periodontal health. In this study, we reviewed studies showing proof of the inhibitory effects of Lactobacillus species on periodontal inflammation. We also explored the rationale and potential for using Lactobacillus species in the management of periodontitis.
© 2022. The Author(s).

Entities:  

Keywords:  Lactobacillus; periodontitis; probiotic

Mesh:

Year:  2022        PMID: 35344188     DOI: 10.1007/s12275-022-1514-4

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   2.902


  84 in total

1.  NOD1 in the modulation of host-microbe interactions and inflammatory bone resorption in the periodontal disease model.

Authors:  João Antônio Chaves de Souza; Sabrina Cruz Tfaile Frasnelli; Fabiana de Almeida Curylofo-Zotti; Mário Julio Ávila-Campos; Luis Carlos Spolidório; Dario Simões Zamboni; Dana T Graves; Carlos Rossa
Journal:  Immunology       Date:  2016-09-06       Impact factor: 7.397

2.  Molecular inflammation and oxidative stress are shared mechanisms involved in both myocardial infarction and periodontitis.

Authors:  Carmen M Díaz; Beatriz Bullon; Rafael J Ruiz-Salmerón; Patricia Fernández-Riejos; Ana Fernández-Palacín; Maurizio Battino; Mario D Cordero; José L Quiles; Alfonso Varela-López; Pedro Bullón
Journal:  J Periodontal Res       Date:  2020-02-27       Impact factor: 4.419

Review 3.  Recent epidemiologic trends in periodontitis in the USA.

Authors:  Paul I Eke; Wenche S Borgnakke; Robert J Genco
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

4.  Interspecies Inhibition of Porphyromonas gingivalis by Yogurt-Derived Lactobacillus delbrueckii Requires Active Pyruvate Oxidase.

Authors:  Louis P Cornacchione; Brian A Klein; Margaret J Duncan; Linden T Hu
Journal:  Appl Environ Microbiol       Date:  2019-08-29       Impact factor: 4.792

5.  Decreased expression of E-cadherin by Porphyromonas gingivalis-lipopolysaccharide attenuates epithelial barrier function.

Authors:  M Abe-Yutori; T Chikazawa; K Shibasaki; S Murakami
Journal:  J Periodontal Res       Date:  2016-03-26       Impact factor: 4.419

6.  Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines.

Authors:  Farzaneh Daghigh; Ruth C Borghaei; Ruth D Thornton; Joseph H Bee
Journal:  J Periodontol       Date:  2002-04       Impact factor: 6.993

7.  Probiotics alter the immune response of gingival epithelial cells challenged by Porphyromonas gingivalis.

Authors:  Emmanuel Albuquerque-Souza; Danilo Balzarini; Ellen S Ando-Suguimoto; Karin H Ishikawa; Maria R L Simionato; Marinella Holzhausen; Marcia P A Mayer
Journal:  J Periodontal Res       Date:  2018-10-04       Impact factor: 4.419

8.  Analysis of the genome sequence of Lactobacillus gasseri ATCC 33323 reveals the molecular basis of an autochthonous intestinal organism.

Authors:  M Andrea Azcarate-Peril; Eric Altermann; Yong Jun Goh; Richard Tallon; Rosemary B Sanozky-Dawes; Erika A Pfeiler; Sarah O'Flaherty; B Logan Buck; Alleson Dobson; Tri Duong; Michael J Miller; Rodolphe Barrangou; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

9.  Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis.

Authors:  Linlin Chen; Yiyou Zou; Jie Peng; Fanggen Lu; Yani Yin; Fujun Li; Junwen Yang
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

Review 10.  Probiotic Species in the Modulation of Gut Microbiota: An Overview.

Authors:  Md Abul Kalam Azad; Manobendro Sarker; Tiejun Li; Jie Yin
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

View more
  1 in total

Review 1.  Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases.

Authors:  Lisa Danielly Curcino Araujo; Flávia Aparecida Chaves Furlaneto; Léa Assed Bezerra da Silva; Yvonne L Kapila
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.